ControversiesChallengesConsensus
}

CX 2022: Dr Rob Hinchliffe on Hurting Leg Challenges

2022-03-24T17:12:58+00:00

“An interdisciplinary problem”

CX 2022 will highlight Hurting Leg Challenges, addressing unbalanced amputation rates based on geography, distilling the underlying causes of “hurting legs” and getting patients into the right hands. Be a part of it – register your place and explore the programme online.

CX Executive Board […]

CX 2022: Dr Rob Hinchliffe on Hurting Leg Challenges2022-03-24T17:12:58+00:00

CX 2022: Haulon, Mastracci and Kölbel on Aortic Challenges

2022-01-12T11:22:00+00:00

Global thought leaders speak to CX, the first opportunity of the year to unite the vascular and endovascular field, face-to-face, about the challenges and opportunities at the crux of the aortic field. You can register with the early bird rates now.

Stéphan Haulon (Paris, France), highlights the […]

CX 2022: Haulon, Mastracci and Kölbel on Aortic Challenges2022-01-12T11:22:00+00:00

CX 2022: Nicholas Inston on Vascular Access Challenges

2021-12-15T11:24:26+00:00

Nicholas Inston (Birmingham, UK) talks to CX about the challenges in creation, maintenance and salvage of vascular access in patients with end stage renal disease. Inston highlights the […]

CX 2022: Nicholas Inston on Vascular Access Challenges2021-12-15T11:24:26+00:00

Vascular Trauma Controversies at CX 2021

2021-04-01T18:09:16+01:00

Christopher Aylwin (UK) talks about resuscitative endovascular balloon occlusion of the aorta (REBOA), which he notes will likely be the biggest controversial topic in this year’s Vascular […]

Vascular Trauma Controversies at CX 20212021-04-01T18:09:16+01:00

CX 2021: Vascular Access programme targets impact of high-flow arteriovenous fistulas

2021-03-26T14:09:26+00:00

International practice differences exist in cannulation and dialysis provision with some approaches aiming for fistulas to suit the logistics of dialysis, rather than best long-term outcomes for the fistula and the patient

The CX 2021 Vascular Access Controversies Programme is designed to showcase the latest advances and disputes […]

CX 2021: Vascular Access programme targets impact of high-flow arteriovenous fistulas2021-03-26T14:09:26+00:00

‘Unacceptably high’ major amputation rates and the effects of COVID on the agenda in Hurting Leg session

2021-03-25T09:33:07+00:00

William Jeffcoate (UK) discusses his upcoming presentation at the Hurting Leg session at CX 2021, titled The impact of socio-economic and clinical variables on the incidence of major amputation in people with diabetic foot ulcers.

The session, which will take place on Thursday 22 April, will shine a […]

‘Unacceptably high’ major amputation rates and the effects of COVID on the agenda in Hurting Leg session2021-03-25T09:33:07+00:00

Lively debates will tackle the biggest controversies in Abdominal Aortic session

2021-03-03T14:40:10+00:00

Colin Bicknell (UK) and Michael Jenkins (UK) will go toe-to-toe in a hotly anticipated debate at CX 2021 titled Standard EVAR can be used in most challenging necks. Bicknell will be arguing for the motion and Jenkins–who is current president of the Vascular Society of Great Britain and Ireland (VSGBI)–will be […]

Lively debates will tackle the biggest controversies in Abdominal Aortic session2021-03-03T14:40:10+00:00

CX Aortic Vienna 2020-Top reasons to attend

2020-08-07T17:02:07+01:00

Top reasons to attend CX Aortic Vienna 2020

  • The inaugural CX Aortic Vienna will focus on the entire aorta, from the valve to iliac arteries
  • CX Aortic Vienna will focus on the thoracic, infrarenal and iliac segments each day
  • CX Aortic Vienna features a world-class aortic faculty
  • CX […]
CX Aortic Vienna 2020-Top reasons to attend2020-08-07T17:02:07+01:00

Aorta to take centrestage and “starring role” at CX Aortic Vienna

2020-07-16T21:45:19+01:00

Roberto Chiesa (Milan, Italy) invites you to the inaugural CX Aortic Vienna Virtual Conference (8–11 September). The conference will focus on cardiovascular aortic advances and classical open and endovascular solutions. The aorta, notes Chiesa, will play the “starring role” at the conference, where open, endovascular and hybrid techniques will be presented along with other “top-level scientific […]
Aorta to take centrestage and “starring role” at CX Aortic Vienna2020-07-16T21:45:19+01:00

Number of vascular surgeons being trained is “woefully inadequate”

2020-03-09T14:43:42+00:00

Sophie Renton (London, UK) moderates a session with Michel Makaroun (Pittsburgh, USA) and Armando Mansilha (Porto, Portugal) where the trio discuss some of the challenges relating to recruitment within the field of vascular surgery.

Makaroun explains that there are two main recruitment pathways into vascular surgery in the USA but notes […]

Number of vascular surgeons being trained is “woefully inadequate”2020-03-09T14:43:42+00:00

CX 2020: What to expect from this year’s Aortic Workshop

2020-03-09T10:48:40+00:00

Kevin Mani (Uppsala, Sweden) chats to BLearning about the upcoming Aortic Workshop at CX 2020 (Charing Cross Symposium; 21–24 April, London, UK), noting how the sessions will give attendees access to experts, the latest technologies and provide a platform for hands-on experience with new devices and imaging technology.

Workshop participants can take this […]

CX 2020: What to expect from this year’s Aortic Workshop2020-03-09T10:48:40+00:00

Michel Makaroun discusses why the CX Symposium is a “special meeting”

2020-03-09T09:09:07+00:00

Roger Greenhalgh (London, UK) speaks to former president of the SVS (2018–2019) Michel Makaroun (Pittsburgh, USA) about the CX Symposium which Makaroun says “always has a special flavour” and is “a special meeting”. Makaroun also touches on some of the similarities and differences between CX and the SVS meeting in […]

Michel Makaroun discusses why the CX Symposium is a “special meeting”2020-03-09T09:09:07+00:00

Long-term partnership helps drive CX Symposium forward

2020-03-06T09:50:48+00:00

Roger Greenhalgh (London, UK) and W L Gore’s Michael Koenke (Flagstaff, USA), take a look back at the history of the Charing Cross Symposium (CX), which began in 1978.

Koenke says that CX is a “special meeting for us”, adding that it is an “opportunity for us to connect with our […]

Long-term partnership helps drive CX Symposium forward2020-03-06T09:50:48+00:00

Scientific level of CX Symposium “very attractive” for attendees

2020-03-06T09:55:51+00:00

Roger Greenhalgh (London, UK) chats with Enrico Ascher (New York, USA) about some of the highlights of the CX Symposium, how it differs to the VEITH symposium in the USA and also how the two complement each other.

Ascher says he is always “totally amazed by the scientific level” of CX, […]

Scientific level of CX Symposium “very attractive” for attendees2020-03-06T09:55:51+00:00

Type II endoleak with secondary sac expansion remains elusive

2020-01-08T13:00:32+00:00

Leading experts including Robert Morgan (London, UK), Richard McWilliams (Liverpool, UK), Stéphan Haulon (Paris, France), Tilo Kölbel (Hamburg, Germany) and Peter Schneider (Honolulu, USA) discuss the various approaches to correcting endoleak during CX 2018 (Charing Cross Symposium; 24–27 April 2018; London, UK).

Type II endoleak with secondary sac expansion remains elusive2020-01-08T13:00:32+00:00
Go to Top